Add to ORKGTabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitor
Objective. To investigate if antibodies towards biological TNF-α inhibitors (anti-TNFi Abs) are pres...
Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis an...
Rheumatoid arthritis (RA) is an immune-mediated condition which primarily affects the joints, but wi...
BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response t...
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-sev...
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an in...
Golimumab, a human antibody to tumour necrosis factor a given by monthly subcutaneous injections, in...
Objectives: The efficacy and safety of 2 different dosing regimens of tabalumab, a monoclonal antibo...
BACKGROUND: Tumour necrosis factor alpha (TNFalpha) neutralising antibody constructs are increasingl...
Item does not contain fulltextThe current pharmacotherapy of rheumatoid arthritis (RA) consists of n...
Toshio Tanaka,1,2 Yoshihiro Hishitani,3 Atsushi Ogata2,3 1Department of Clinical Application of Biol...
The introduction of TNF- alpha -inhibiting biologicals has been a major therapeutic breakthrough in ...
Contains fulltext : 80642.pdf (publisher's version ) (Closed access)BACKGROUND: Tu...
Background. Antitumor necrosis factor (anti-TNF) drugs have been applied for rheumatoid arthritis (R...
Rheumatoid arthritis (RA) is an immune-mediated condition which primarily affects the joints, but wi...
Objective. To investigate if antibodies towards biological TNF-α inhibitors (anti-TNFi Abs) are pres...
Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis an...
Rheumatoid arthritis (RA) is an immune-mediated condition which primarily affects the joints, but wi...
BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response t...
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-sev...
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an in...
Golimumab, a human antibody to tumour necrosis factor a given by monthly subcutaneous injections, in...
Objectives: The efficacy and safety of 2 different dosing regimens of tabalumab, a monoclonal antibo...
BACKGROUND: Tumour necrosis factor alpha (TNFalpha) neutralising antibody constructs are increasingl...
Item does not contain fulltextThe current pharmacotherapy of rheumatoid arthritis (RA) consists of n...
Toshio Tanaka,1,2 Yoshihiro Hishitani,3 Atsushi Ogata2,3 1Department of Clinical Application of Biol...
The introduction of TNF- alpha -inhibiting biologicals has been a major therapeutic breakthrough in ...
Contains fulltext : 80642.pdf (publisher's version ) (Closed access)BACKGROUND: Tu...
Background. Antitumor necrosis factor (anti-TNF) drugs have been applied for rheumatoid arthritis (R...
Rheumatoid arthritis (RA) is an immune-mediated condition which primarily affects the joints, but wi...
Objective. To investigate if antibodies towards biological TNF-α inhibitors (anti-TNFi Abs) are pres...
Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis an...
Rheumatoid arthritis (RA) is an immune-mediated condition which primarily affects the joints, but wi...